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Abstract: Rattlesnake venoms may be classified according to the presence/absence and relative
abundance of the neurotoxic phospholipases A2s (PLA2s), such as Mojave toxin, and snake venom
metalloproteinases (SVMPs). In Mexico, studies to determine venom variation in Mojave Rattlesnakes
(Crotalus scutulatus scutulatus) are limited and little is known about the biological and proteolytic
activities in this species. Tissue (34) and venom (29) samples were obtained from C. s. scutulatus from
different locations within their distribution in Mexico. Mojave toxin detection was carried out at the
genomic (by PCR) and protein (by ELISA) levels for all tissue and venom samples. Biological activity
was tested on representative venoms by measuring LD50 and hemorrhagic activity. To determine the
approximate amount of SVMPs, 15 venoms were separated by RP-HPLC and variation in protein
profile and proteolytic activity was evaluated by SDS-PAGE (n = 28) and Hide Powder Azure
proteolytic analysis (n = 27). Three types of venom were identified in Mexico which is comparable to
the intraspecific venom diversity observed in the Sonoran Desert of Arizona, USA: Venom Type A
(∼Type II), with Mojave toxin, highly toxic, lacking hemorrhagic activity, and with scarce proteolytic
activity; Type B (∼Type I), without Mojave toxin, less toxic than Type A, highly hemorrhagic
and proteolytic; and Type A + B, containing Mojave toxin, as toxic as venom Type A, variable
in hemorrhagic activity and with intermediate proteolytic activity. We also detected a positive
correlation between SVMP abundance and hemorrhagic and proteolytic activities. Although more
sampling is necessary, our results suggest that venoms containing Mojave toxin and venom lacking
this toxin are distributed in the northwest and southeast portions of the distribution in Mexico,
respectively, while an intergradation in the middle of both zones is present.
Keywords: Mojave Rattlesnakes; Mojave toxin; PLA2s; SVMPs; venom phenotypes; hemorrhagic activity
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Key Contribution: Crotalus scutulatus scutulatus individuals with Type A, Type A + B, and Type B
venoms were confirmed in Mexico. Proteolytic and biological activity shows high variation among
individuals with a specific geographic pattern.
1. Introduction
Venoms of snakes belonging to the Family Viperidae are comprised of a complex mixture of
proteins that can be grouped into families based on their structural similarities [1]. The most common
protein families in rattlesnake venoms are: Zn2+ metalloproteinases, phospholipases A2s (PLA2s),
serine proteinases, C-type lectins (CTLs), disintegrins, L-amino acid oxidase (LAAOs), cysteine rich
secretory proteins (CRiSPs), bradykinin potentiating peptides (BPPs), and myotoxins [2–7]. It has
been proposed that rattlesnake venoms be classified into two groups according to their toxicity and
proteolytic activity: Type I venoms are characterized by high proteolytic activity and moderate toxicity,
while Type II venoms are more toxic but their proteolytic activity is lower or non-detectable [2].
The family responsible for most of the proteolytic activity in Type I venom is the snake venom
metalloproteinase (SVMPs). In Type II venoms, the protein that is responsible for their high toxicity
is a presynaptically acting β-neurotoxic PLA2 called Mojave toxin (MTX) originally described in
Mojave Rattlesnakes (Crotalus scutulatus scutulatus) but also found in C. viridis, C. oreganus, C. mitchelli,
and C. tigris [8,9]. This toxin is homologous in structure to Crotoxin in C. durissus and C. vegrandis,
and Canebrake toxin in C. horridus [8,10].
SVMPs are enzymes formed by multiple domains whose main toxic effects are due to the
disruption of the hemostatic system. SVMPs are classified into three groups (P-I, P-II, and P-III)
according to the number of domains they contain. PI SVMPs are composed of only a metalloproteinase
domain (M) while P-II SVMPs contain an additional disintegrin domain (D). P-III SVMPs are further
divided into P-IIIa, P-IIIb, P-IIIc and P-IIId based on post-translational modifications that these proteins
can exhibit including presence of additional domains and domain hydrolysis and dimerization [11].
SVMPs induce several pathophysiological effects such as myonecrosis, blistering, inflammation,
coagulopathy, and inhibition of platelet aggregation, but are most known for their capacity to generate
local and systemic hemorrhage [12]. Bleeding has been associated with the ability of SVMPs to
hydrolyze key components of basal membranes such as type IV, VI and XV collagens and perlecan [13].
Additionally, SVMPs are known for their proteolytic activity on other substrates such as Hide Powder
Azure (HPA), casein, azocasein, and some proteins of the coagulation cascade including fibrin,
fibrinogen, prothrombin, and factor X [14,15].
Mojave toxin, isolated for the first time from Mojave Rattlesnake venom, is a heterodimeric PLA2
composed of one non-enzymatic acidic subunit (90 amino acids, 9.6 kDa, pI = 3.6) and one enzymatic
basic subunit with PLA2 activity (128 amino acids, 14.6 kDa, pI = 9.6) associated by non-covalent
bonds [16]. Neurotoxic, cardiotoxic, and myonecrotic activities have been attributed to MTX and its
toxicity has been calculated to be as low as 0.056 mg/kg i.v. via LD50 tests in mice [16–19]. MTX is
encoded by two genes composed of four exons and three introns each [20] and it is necessary that both
MTX genes be expressed for the completely functional protein to be present in the venom [21]. MTX
is structurally similar to other Crotalus neurotoxins such as Crotoxin (from the C. durissus complex).
Both toxins share 96% and 99% of amino acid sequence identity for the acidic and basic subunits,
respectively, and induce similar biological effects [22–24]. Previous reports have shown that antibodies
against the basic subunit of Mojave toxin are able to react with the basic subunit of Crotoxin from
C. d. terrificus venom, corroborating the high structural similarity between both proteins [25,26].
The dichotomy between toxicity and proteolytic activity can also be found within a single species
of rattlesnake. In these cases, the phenotypes are referred to as Type A (neurotoxic and with scarce
hemorrhagic and proteolytic activities—similar to Type II) and Type B (hemorrhagic and proteolytic and
without neurotoxins—similar to Type I). Intra-specific variation in biochemical and biologic properties
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of rattlesnake venoms has been broadly documented [27–30]. Particularly, geographic venom variation
has been demonstrated in several rattlesnakes including Mojave Rattlesnakes (C. scutulatus scutulatus).
Three venom phenotypes were originally described for populations of Mojave Rattlesnakes from the
Sonoran Desert in the United States: Type A, Type B, and Type A + B (containing a combination
of neurotoxic, hemorrhagic, and proteolytic activities) [31–33]. Massey et al. [5] extended this
classification to six venom phenotypes (A, B, C, D, E, and F) varying from each other in the presence and
abundance of three main proteins including Mojave toxin, SVMPs and myotoxin a (herafter myotoxin).
The first three phenotypes (A, B, and C) contain mostly SVMPs and very little if any Mojave toxin or
myotoxin. The last three phenotypes (D, E, and F) are composed mostly for Mojave toxin and myotoxin
with scarce or no SVMPs.
Mojave Rattlesnakes are distributed in the southwestern United States and Mexico [34]. In Mexico,
the subspecies C. s. scutulatus can be found in the states of Aguascalientes, Chihuahua, Coahuila, Durango,
Guanajuato, Jalisco, Nuevo León, Queretaro, San Luis Potosí, Sonora, Tamaulipas, and Zacatecas [34].
Although the composition of Mojave Rattlesnake venom in the United States has been broadly studied,
in Mexico the only study of venom composition was carried out in La Comarca Lagunera, Mexico,
a region located at the north-central portion of Mexico in the states of Coahuila and Durango. In this
region, C. s. scutulatus displayed venom devoid of Mojave toxin and with biochemical and biological
activities similar to Type B venom from the Sonoran Desert in the United States [35]. However, it has
not been determined if Mojave rattlesnake individuals with neurotoxic (Type A) and/or neurotoxic and
hemorrhagic (Type A + B) venom are present in Mexico nor whether Type B venom in Mexico and the
U.S. are the same. Therefore, the goal of this study was to determine if the venom of Mojave Rattlesnakes
in the southern portion of C. s. scutulatus’ distribution is as diverse as it is in the U.S.A.
2. Results
2.1. Mojave Toxin Detection via PCR
Thirty-four C. s. scutulatus DNA samples from Mexico were tested for the presence of the genes of
the two Mojave toxin subunits and compared to neurotoxic and non-neurotoxic C. s. scutulatus controls
from Arizona. PCR amplification with both the acidic (MTXA) and basic (MTXB) primers generated
fragments of ∼1000 bp in 41% of the samples (Tables 1–3).
Table 1. Biologic and proteolytic activities of C. s. scutulatus with Type B venom from Mexico.
Geographic
Location
Genomic Mojave
% of MTX
in Venom
% of SVMPs LD50
(mg/kg)
Hemorrhagic HPA
ID Toxin Presence in Venom Activity Hydrolysis
(MTXA/MTXB) (RP-HPLC) (Intensity) (U/mg)
CSS01 Aldama-Coyame, Chih. No/No 0 ND ND 3 42.4 ± 1.8
CSS02 Aldama-Coyame, Chih. No/No 0 40 ND 4 39.3 ± 1.8
CSS03 Aldama-Coyame, Chih. No/No 0 ND ND 4 46.5 ± 10.7
CSS04 Aldama-Coyame, Chih. No/No 0 ND 0.622 4 46.5 ± 3.1
CSS26 Aldama-Coyame, Chih. No/No 0 40 0.842 3 31.9 ± 0.6
CSS27 Aldama-Coyame, Chih. No/No 0 45 0.863 3 33.3 ± 2.4
CSS09 Matamoros, Coah. No/No 0 ND ND 4 42.4 ± 1.8
CSS12 Matamoros, Coah. No/No 0 40 0.590 4 42.4 ± 1.8
CSS13 Matamoros, Coah. No/No 0 ND ND ND ND
CSS20 Matamoros, Coah. No/No 0 ND 0.566 3 35.6 ± 1.9
CSS06 Tanque Aguilereño, Coah. No/No 0 ND ND ND 35.5 ± 1.1
CSS17 Tanque Aguilereño, Coah. No/No 0 ND ND ND ND
CSS18 Tanque Aguilereño, Coah. No/No 0 44 0.300 4 36.0 ± 0.3
CSS19 Tanque Aguilereño, Coah. No/No 0 ND 0.584 3 32.1 ± 1.8
CSS29 Tanque Aguilereño, Coah. No/No 0 ND ND 4 37.2 ± 3.1
CSS05 Peñón Blanco, Durango No/No 0 53 0.684 4 36.3 ± 0.6
CSS07 Mapimí, Durango No/No 0 ND ND 4 42.1 ± 4.2
CSS36 Plateros, Zacatecas No/No 0 34 0.890 4 36.9 ± 0.9
ASU36103 Arizona, USA No/No 0 34 1.090 3 34.9 ± 0.2
ND: not determined.
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Table 2. Biologic and proteolytic activities of C. s. scutulatus with Type A venom from Mexico.
Geographic
Location
Genomic Mojave
% of MTX
in Venom
% of SVMPs LD50
(mg/kg)
Hemorrhagic HPA
ID Toxin Presence in Venom Activity Hydrolysis
(MTXA/MTXB) (RP-HPLC) (Intensity) (U/mg)
CSS15 Tepezala, Ags. Yes/Yes 18 15 0.152 0 4.0 ± 0.2
CSS16 Tepezala, Ags. Yes/Yes 12 ND 0.102 0 5.0 ± 0.3
CSS21 Tepezala, Ags. Yes/Yes 21.5 13 0.150 0 2.6 ± 0.3
CSS33 El Llano, Ags. Yes/Yes 27.7 11 0.092 0 2.7 ± 0.3
CSS34 El Llano, Ags. Yes/Yes 25.6 10 0.177 0 5.8 ± 0.2
CSS35 Rio San Pedro, Ags. Yes/Yes 22.5 11 0.098 0 3.0 ± 0.4
CAS259916 Arizona, USA Yes/Yes 37.9 1 0.130 0 5.7 ± 0.7
ND: not determined.
Table 3. Biologic and proteolytic activities of C. s. scutulatus with Type A + B venom from Mexico.
Geographic
Location
Genomic Mojave
% of MTX
in Venom
% of SVMPs LD50
(mg/kg)
Hemorrhagic HPA
ID Toxin Presence in Venom Activity Hydrolysis
(MTXA/MTXB) (RP-HPLC) (intensity) (U/mg)
CSS22 Genaro García, Zacatecas Yes/Yes 17 30 0.136 4 29.2 ± 2.5
CSS23 Ojuelos, Jalisco Yes/Yes 29.5 ND ND 2 25.5 ± 1.3
CSS24 Ojuelos, Jalisco Yes/Yes 29 ND ND 3 39.8 ± 1.3
CSS25 Ojuelos, Jalisco Yes/Yes 21 23 0.203 2 21.8 ± 0.2
CSS30 La Asención, Nuevo León Yes/Yes 21.7 34 0.179 4 30.5 ± 2.3
ND: not determined.
In general, individuals containing acidic and basic subunits were found in the southeast portion
of the sampling area, while snakes lacking Mojave toxin genes were distributed in the northwest
region (Figure 1). Five samples (CSS08, CSS10, CSS11, CSS14 and CSS28, from Matamoros, Coahuila;
San Tiburcio, Zacatecas; General Cepeda, Coahuila; Aguascalientes, Aguascalientes; and El Mezquite,
Coahuila, respectively) were only analyzed for the presence of the Mojave toxin genes because they
were collected dead on the road and no venom was available (Figure 1).
Therefore, these five samples were not included in Tables 1–3 because these assays were not
possible. Samples CSS10, CSS11 and CSS14 were positive for both Mojave toxin genes. To corroborate
that fragments obtained by PCR correspond to MTXA, the fragment obtained with the acidic subunit
primers from individual CSS11 was sequenced and analyzed for similarities with other sequences on
GenBank. Our sequence (GenBank Accession MG574869) is 99% percent similar to the acidic subunit
of Mojave toxin from C. s. scutulatus from the United States (GenBank Accession KX211993 [36]).
2.2. Mojave Toxin Detection by ELISA
Twenty-nine C. s. scutulatus venoms were tested for Mojave toxin using ELISA (Tables 1–3).
Eleven venoms (38%) tested positive for Mojave toxin (Tables 2 and 3). All individuals containing
Mojave toxin in their venom were positive for both Mojave toxin genes using PCR and no individuals
containing Mojave toxin genes lacked the protein in their venom. The approximate amount of Mojave
toxin in venoms calculated by ELISA was variable, ranging from 12% (CSS16) to 29.5% (CSS23)
(Tables 2 and 3). The percentage of Mojave toxin in the Type A venom control from Arizona was 37.9%.
As expected, the Type B venom control did not contain Mojave toxin.
2.3. Median Lethal Dose (LD50)
Eighteen venoms were analyzed for toxicity in mice (Tables 1–3). LD50 values for Mexican
neurotoxic venoms ranged from 0.092 mg/kg to 0.203 mg/kg with an average of 0.143 mg/kg
(Tables 2 and 3). In addition, mice injected with these venoms displayed flaccid paralysis of the
hind limbs, a neurotoxic effect. In contrast, venoms lacking Mojave toxin were less toxic with LD50
values range from 0.300 mg/kg to 0.890 mg/kg with an average of 0.660 mg/kg (Table 1). Based on
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this, venoms containing Mojave toxin were approximately five times more toxic than venoms lacking
the neurotoxin. The controls from Arizona had LD50 values of 0.13 mg/kg and 1.09 mg/kg for Type A
and Type B venoms, respectively.
Figure 1. Geographic distribution of C. s. scutulatus individuals with and without Mojave toxin
genes in Mexico. Individuals containing Mojave toxin are represented with triangles (red = Type
A, purple = TypeA + B, and black = collected dead), while individuals lacking Mojave toxin genes
(Type B) are shown with circles (blue = venom assays conducted, black = collected dead). Numbers
correspond to the individuals in Tables 1–3 without the C.S.S. abbreviation. The outline zone represents
C. s. scutulatus’ distribution, the shaded area represents the Chihuahuan Desert, and colors on the map
represent elevation where light blue is closest to sea level and white is highest above sea level.
2.4. Hemorrhagic Activity
Twenty-six venoms were tested for hemorrhagic activity (Tables 1–3). Fifteen venoms lacking
Mojave toxin induced significant hemorrhagic activity (values of 3 and 4) and were classified as Type B
(Table 1). Interestingly, five neurotoxic venoms also caused hemorrhaging although with variable
intensity; these venoms were classified as Type A + B (Table 3). Venoms CSS23, CSS24, CSS25 from
Ojuelos, Jalisco caused hemorrhage with values of 2, 3, and 2, respectively, while venoms from Genaro
Garcia, Zacatecas (CSS22), and La Ascensión, Nuevo León (CSS30) had values of 4. Six neurotoxic
venoms from Aguascalientes, and the neurotoxic control did not cause hemorrhaging and were
classified as Type A (Table 2). The Type B venom from Arizona had a hemorrhage value of 3 (Table 1).
2.5. Hide Powder Azure (HPA) Hydrolysis
Twenty-seven venoms were tested for HPA hydrolysis (Tables 1–3). Venoms displayed variable
proteolytic activity to HPA. Venoms lacking Mojave toxin (Type B) were the most proteolytic
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with values ranging from 31.9 to 46.5 U/mg (Table 1). Venoms with both Mojave toxin and
hemorrhagic activity (Type A + B) hydrolyzed HPA in values ranging from 21.8 to 39.8 U/mg (Table 3).
Finally, neurotoxic venoms without hemorrhagic activity (Type A) were less proteolytic than the first
two groups of venoms with values of enzymatic activity from 2.6 to 5.8 U/mg (Table 2).
2.6. Reverse Phase HPLC for MTX and SVMPs Detection
Fifteen representative venoms (Type A—CSS15, CSS21, CSS33, CSS34 and CSS35; Type B—CSS02,
CSS05, CSS12, CSS18, CSS26, CSS27 and CSS36; and Type A + B—CSS22, CSS25 and CSS30)
from Mexican C. s. scutulatus and both controls were fractionated by RP-HPLC (representative
chromatograms are shown in Figure 2 and remaining in Figure A1).
The fraction that eluted at 42 min was the acidic subunit of Mojave toxin based on our
MALDI-TOF-TOF analysis which obtained the three chains that make up the subunit: (1) alpha
chain: SSYGCYCYCGAGGAGGQGWPWPQDASDRCCFEHDCCYAKLTGCDPTTTD; (2) beta chain:
RQEDGEIVCGGDDPCGTQQICECDKAAAICFRDSMN; and (3) gamma chain: RFSPENCQGESQPC
(Figure 2). This matched the sequence reported for the acidic subunit of Mojave toxin in the Uniprot
database (P18998) [22]. A high peak eluting at approximately 52 min was detected in Type A and
Type A + B venoms but was absent in Type B venoms (Figure 2). This peak corresponded to the basic
subunit of Mojave toxin as demonstrated by N-terminal sequence analysis (HLLQFNKMIKFETR) and
its molecular weight was 14.2 kDa and 14.3 kDa (by mass spectrometry), indicating the presence of at
least two isoforms. The percentage of SVMPs in Type A, Type B, and Type A + B venoms was notably
different (Tables 1–3 and Figure 2). Type A venom from Arizona and five venoms from Aguascalientes
showed lower SVMPs abundance (1–15%) compared to the other eleven venoms analyzed. Conversely,
the percentage of SVMPs in non-neurotoxic venoms ranged from 34–53%. Chromatograms of venoms
containing neurotoxic and hemorrhagic activities revealed an intermediate SVMPs percentage with
values from 23–34%. A significant positive correlation (r2 = 0.865; F = 84.4; df = 1.13; p < 0.001)
was observed between the SVMPs percentage and proteolytic activity (HPA hydrolysis) of Mexican
C. s. scutulatus venoms, suggesting that as the amount of SVMPs increases, the proteolytic activity also
increased (Figure 3).
2.7. SVMPs Detection by Western Blot
To confirm the fractions eluted after 78 min by RP-HPLC were SVMPs, a Western blot analysis
was carried out. Figure 4A shows a SDS-PAGE with the venoms and fractions that were transferred to
nitrocellulose membrane. Antibodies against SVMPs were unable to bind SVMPs in Type A venom
(Figure 4B) or its fractions (data not shown).
Two antibody recognition zones (∼24 kDa and∼62 kDa) were detected in whole Type B and CSS22
venoms and the reverse-phase HPLC fractions from the Type B venom. Unexpectedly, reverse-phase
HPLC fractions from the CSS22 venom lacked the ∼24 kDa band but displayed an additional band
of ∼55 kDa similar to the P-III SVMP used as positive control. No bands were seen in the lanes
corresponding to Crotoxin and SVSPs which corroborates the antibody’s specificity.
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Figure 2. Representative reverse-phase HPLC chromatograms of the three C. s. scutulatus venom types
found in Mexico. (A) Type A control venom from Arizona; (B) Type B control venom from Arizona;
(C,D) Type A venoms from Mexico; (E,F) Type B venoms from Mexico; (G,H) Type A + B venoms
from Mexico. Retention time is along the x axis for each panel and labeled every twenty minutes.
Proteins were detected at 215 nm and absorbance is indicated on the left axis. The acetonitrile gradient is
shown in the HPLC graph and the percentage value corresponds to the right axis for each panel. Acidic
(MTXA) and basic (MTXB) subunits of Mojave toxin and snake venom metalloproteinases (SVMPs) are
illustrated in blue, green and red, respectively. The remaining chromatograms are in Figure A1.
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Figure 3. Relationship between the SVMP percentage and proteolytic activity (HPA hydrolysis) of
venoms from fifteen C. s. scutulatus from Mexico. Type A, B and A + B venoms are red diamonds,
blue circles, and purple triangles, respectively.
Figure 4. (A) SDS-PAGE; and (B) Western blot analysis for SVMPs detection of Type A and Type
B venoms from Arizona as well as CSS22 venom from Mexico. Whole crude venoms are indicated
with C and reverse-phase HPLC fractions eluted after 78 min are indicated with F. Ctx = Crotoxin;
SVSP = snake venom serine protease; P-III SVMP = type III snake venom metalloproteinases.
2.8. SDS-PAGE
Twenty-eight C. s. scutulatus venoms from Mexico and four samples from the USA (two Type A
and two Type B) were separated by SDS-PAGE. Notable differences were detected in the presence and
intensity of several protein bands among the different venoms analyzed (Figure 5).
The most prominent differences were observed in the range of 50 to 75 kDa, where venoms
displayed a prominent band of 62 kDa (likely PIII-SVMPs); however, this band was much less visible
in the five Type A venoms from Aguascalientes (CSS15, CSS21, CSS33, CSS34, and CSS35). Inversely,
venoms with faint 62 kDa band displayed an intense band of 15 kDa (likely the basic subunit of Mojave
toxin). The zone near 15 kDa was more heterogeneous (in number and intensity of bands) in venoms
lacking Mojave toxin but, in general, bands were less intense than those displayed by venoms with
Mojave toxin. Interestingly, ten of the eighteen Type B Mexican venoms (CSS01, CSS05, CSS06, CSS07,
CSS09, CSS12, CSS13, CSS17, CSS20, and CSS29) and the Type B control from NNTRC (National
Toxins 2018, 10, 35 9 of 19
Natural Toxins Research Center in Kingsville, Texas) had a small band of less than 10 kDa, which was
absent in the rest of venoms and likely corresponds to myotoxins.
Figure 5. SDS-PAGE of C. s. scutulatus venoms from Mexico under reducing conditions. NNTRC A
and B correspond to pooled Type A and Type B venoms from National Natural Toxins Research Center,
respectively; A, CAS259916 and B, ASU36103 represent individual Type A and Type B venoms from
Arizona, respectively. kDa: kilodaltons. Bands with molecular weight in the ranges of 75 to 50 kDa are
likely SVMPs and ∼15 kDa are likely PLA2s.
3. Discussion
We found Mojave toxin in 11 of 29 individuals of C. s. scutulatus from Mexico at both the genomic
(PCR) and protein (ELISA) levels. Additionally, three samples from Mojave Rattlesnakes collected
dead were also positive for Mojave toxin using PCR (CSS10, CSS11, and CSS14), although we could
not confirm the presence of Mojave toxin in their venom because venom could not be collected.
However, considering that in all other samples where Mojave toxin genes were amplified, the protein
was observed in the venom, it is highly probable that these three individuals had Mojave toxin in
their venom as well. We successfully determined the presence of Mojave toxin in C. s. scutulatus
venoms from Mexico using monoclonal and polyclonal antibodies against Crotoxin. We did not
find any individuals that were negative for Mojave toxin by PCR and positive by ELISA, indicating
the specificity of the antibodies for neurotoxic PLA2s (Tables 1–3). These results corroborate the
effectiveness of both techniques to detect Mojave toxin in C. s. scutulatus and are in agreement with
other reports [21,37,38]. In addition, we confirmed the presence of Mojave toxin via RP-HPLC. Venoms
that were positive for Mojave toxin in our ELISA anaylsis show two peaks at approximately 42 and
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52 min in our chromatograms that were absent in venoms negative for Mojave toxin based on ELISA
(Figure 2). We confirmed, via mass spectrometry and N-terminal sequencing analysis, that these
two peaks correspond to the acidic and basic subunites of Mojave toxin, respectively. Using the same
gradient, Castro et al. [27] detected the basic subunit of crotoxin at the same retention time in venoms of
C. simus from Mexico. This indicates similar physiochemical characteristics between both neurotoxins.
We observed and characterized three types of venoms within C. s. scutulatus in Mexico according
to their biological and biochemical activities and the presence/absence of Mojave toxin. First, Type A,
containing Mojave toxin, was highly toxic, lacked hemorrhagic activity, and its proteolytic activity was
minimal (Table 2). Second, Type A + B, expressed Mojave toxin, was as toxic as the Type A venom,
was hemorrhagic, and its capacity to hydrolyze HPA was intermediate (Table 3). The third, Type B,
did not contain Mojave toxin, its LD50 was several times higher (i.e. less toxic) than the first two
venom types, and was more hemorrhagic and proteolytic than the other two venom types (Table 1).
This demonstrates conclusively that the three phenotypes are not just found in Arizona [39] and that
venom variability of C. s. scutulatus in Mexico is just as diverse as it is in southern Arizona [5].
In other studies, it has been demonstrated that SVMPs are the proteins that elute last in
RP-HPLC [5,27,40]. Similar to these reports, we detected important variation in the number and
height of the peaks in the area after 78 min of elution in fifteen C. s. scutulatus venoms from Mexico
(Figure 2). We confirmed via Western blot that this area contained SVMPs (Figure 4). Although only
three venoms (Type A and Type B controls, and a venom Type A + B from Mexico) were tested for
the presence of SVMPs by Western blot, it is clear that the amount of SVMPs in venom Type A is
minimal or absent completely (no bands were detected by Western blot), while Type B and A + B
venoms contained at least two groups of SVMPs according to their molecular mass: ∼55 kDa and
∼62 kDa likely P-III isoforms and ∼24 kDa likely P-I SVMPs (Figure 4). These results were congruent
with those observed in SDS-PAGE where venoms without hemorrhagic activity displayed thin bands
in the zone of 50–75 kDa indicating minimal presence of P-III SVMPs (Figure 5). Our results also agree
with those of Massey et al. [5] which reported that Mojave Rattlesnakes with Type B or Type A + B
venom from Arizona contain two types of SVMPs: P-I (23 kDa) and P-III (48 kDa and 69 kDa), with the
P-III being more abundant.
A positive correlation between the amount of SVMPs and proteolytic and hemorrhagic activities
was noted (Figure 3). Venoms with the highest amount of SVMPs were the most proteolytic and
hemorrhagic (Table 1). Inversely, venoms with a limited amount of SVMPs were least proteolytic
and hemorrhagic. Dagda et al. [41] proposed for C. s. scutulatus that variation in hemorrhagic and
proteolytic activities can be associated with structural differences in the metalloproteinase domain
and/or differential metalloproteinase gene expression ligated to polymorphisms in the gene region
that encode the metalloproteinase domain. In agreement with this hypothesis, variation in the
proteolytic (gelatinase) activity related to SVMPs expression variation has been reported in the Eastern
Diamondback Rattlesnake (C. adamanteus) indicating that differential gene expression can have an
important influence in the venom’s biological activities [42].
The variation in biological and biochemical activities in the venom of individual C. s. scutulatus
specimens from Mexico reported here could have important implications in human envenomation
presented in this country. In Mojave Rattlesnakes from the United States, neurotoxic venoms were
approximately seven times more toxic in mice than the hemorrhagic ones [33]. Similarly, neurotoxic
venoms from Mexico were about five times more lethal than venoms lacking Mojave toxin.
The probability of intubation or death increases with the presence of neurotoxic components in
venom [5]. Thus, despite the lack of clinical reports that would help to have a better correlation
between venom types and clinical effects, more severe envenomation could be expected in areas of
Mexico where Type A or Type A + B venoms are distributed. Moreover, regional variation in the
number and relative abundance of the protein families in snake venoms has important implications
in the antivenom effectiveness. Due to antivenoms being made with different venom immunization
mixtures, only those proteins with similar structure to those used in the immunization mixture will
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be recognized by the antivenom. Hence, if venoms in some areas are quite different to those used in
the immunization of animals for the antivenom production, the capacity of antivenom to neutralize
these particular toxins will be limited [43]. For example, the Mexican antivenom Antivipmyn had
difficulties neutralizing neurotoxic venoms of C. s. scutulatus from Arizona and Texas and C. s. salvini
from Mexico [44]. Therefore, knowledge of the areas in Mexico with variable venom is important to
improve the selection of the venom mixture used to create Mexican antivenom.
Several hypotheses have been proposed to explain geographic venom variation in rattlesnakes.
These hypotheses include rattlesnake hybridization [21,30], prey size (the bigger the prey,
more metalloproteinases required to digest), geographic latitude and/or altitude (if the
environmental thermal conditions are quite variable such as extremes of latitude and/or altitude,
more metalloproteinases are required to degrade tissues) [2], and prey stability in the habitat
(places where a substantial recent shift in prey has occurred, Mojave toxin is retained as result of
strong selection for high toxicity) [45]. In Mexico, C. s. scutulatus are predominately distributed in two
physiographic regions: uplands and lowlands of the North and the Central Mesa. The uplands and
lowlands of the North are relatively flat and located in three states, Chihuahua, Coahuila, and Durango,
with an arid/semiarid climate and an annual amount of precipitation varying from 125 to 400 mm.
The average altitude is approximately 1000 m.a.s.l. The vegetation in this area is comprised primarily of
desert microphyllous matorral and desert rosetephylous matorral [46]. On the other hand, the Central
Mesa includes portions of the states of Zacatecas, San Luis Potosi, Guanajuato, Durango, Jalisco,
Aguascalientes, and Queretaro. The minimum elevation in the Central Mesa province is 1180 m.a.s.l,
while the highest point is 3200 m.a.s.l. The climate in this area is semiarid; however, differences in
elevation results in sharp contrast between close localities in their climatic conditions. The precipitation
ranges from 300 mm to 900 mm. The vegetation consists of rosetophyllous matorrals and matorral
with cacti and natural grasslands. An interesting feature of the climate in this area is its inverted
zonality: the temperatures decrease and precipitation increases from north to south [46]. Individuals
with venom Type A and Type A + B were found mainly in the Central Mesa (a higher and cooler place),
while individuals with venom Type B were located mostly in the uplands and lowlands of the North
(lands with low altitudes and higher temperatures, Figure 1). The only exception was the individual
CSS36 from Plateros, Zacatecas who lacked Mojave toxin despite having been found at higher elevation
comparing to the other Type B venoms. A similar pattern was observed in Crotalus oreganus helleri
venom where geographic venom variation was related to altitude differences, so, individuals living in
the higher altitude and greatest temperature fluctuations had Type A venom lacking SVMPs almost
entirely [29]. Although more sampling is needed, it is possible that climatic differences in the subregions
(that might represent different evolutionary environmental pressures) are, in part, associated with the
venom variation seen in the C. s. scutulatus from Mexico. This hypothesis would need to be tested in
conjunction with environmental data. In addition, other studies have hypothesized that transition
between lowland Chihuahuan desert habitat and higher elevation semi-arid habitat in the Central
Mesa could have formed a biogeographic barrier for some species [47,48]. Finally, considering that
Mojave Rattlesnakes with venom Type A + B were found in an area located in the middle between
individuals with venom B (located further north) and A (located further south), an intergrade zone is
likely, similar to the one described in Arizona [32].
4. Conclusions
In conclusion, C. s. scutulatus individuals with Type A, Type A + B, and Type B venoms are
distributed in Mexico. Individuals with Type B venom seem to be distributed in the northwest
region and individuals with Type A and A + B venoms are found in the southeast region.
Additionally, we found an interesting tendency in which individuals containing Mojave toxin were
generally detected in areas with higher elevation compared to Type B venoms, however, this same
tendency has not been noted in C. s. scutulatus individuals from the United States. In this manner, more
sampling is needed to completely delimit the areas where C. s. scutulatus with venoms A, B, and A + B
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are distributed in Mexico and to test the hypothesis that altitude is an important environmental factor
influencing the venom variation in the Mojave rattlesnake.
As previously reported, venoms lacking Mojave toxin were more hemorrhagic and proteolytic
than venoms containing the neurotoxin and this difference is possibly associated to variations in the
amount of SVMPs present in the venoms. Mexican Mojave Rattlesnakes with Type A and Type B
venom were similar in biological (toxicity and hemorrhagic activity) and biochemical (proteolytic
activity and protein profile) properties to those from Arizona used as controls and published studies
of C. s. scutulatus in the U.S.
5. Materials and Methods
5.1. Ethics Statement
We followed the guidelines described by the live animal use committees of the Facultad de
Ciencias Biológicas at UJED, the Universidad Nacional Autónoma de México, and the Secretaría de
Medio Ambiente y Recursos Naturales (SEMARNAT) of Mexico as well as developing our protocols in
accordance with the American Society of Ichthyologists and Herpetologists guidelines for use of live
amphibians and reptiles. Animal care and use protocols involving snakes in the USA were approved
by UCF’s Institutional Animal Care and Use Committee under protocol 13-17W. SEMARNAT issued
collecting permits (SGPA/DGVS/01090/17 and 03562/15) for samples collected in Mexico and the
controls from the U.S. were collected under State of Arizona Game and Fish Department (SP628489,
SP673390, SP673626, SP715023).
5.2. Crotalus scutulatus scutulatus Sampling
Blood and venom samples were obtained from twenty-nine C. s. scutulatus from different areas
of Mexico. Additionally, five tissue samples of dead individuals were collected from animals that
were hit by cars. Venom and blood from two Mojave Rattlesnakes with Type A and Type B venom
from Arizona were used as controls. To reduce the number of mice sacrificed in this study and to
conserve venom (snakes were milked once and a variable amount of venom was obtained from each
snake), venom analyses were prioritized based on importance and amount of venom available for
subsequent analyses.
5.3. PCR Detection of Mojave Toxin Genes
Genomic DNA was extracted from blood or tissue using the DNeasy R© Blood and Tissue kit
(QIAGEN, Valencia, CA, USA) following the manufacturer’s instruction. Detection of portions of the
MTXA (F 5′-TGCGGGGAGAAGTGGTATTT-3′; R 5′-GCAATTTTCGGGCGAGAACC-3′) and MTXB
(F 5′-ACCTGCTGCAATTCAACAAGA-3′; R 5′-CGAGAGTCCGGGTAAAACAT-3′) genes was carried
out by PCR using the primers designed by Zancolli et al. [21]. The PCR mix was made as follows:
DNA (100–300 ng), primers (0.2 µM), Go Taq R© DNA polymerase
(Promega, Fitchburg, WI, USA, 0.5 units), dNTP mix (0.1 mM), and MgCl2 (1.5 mM), in a total
volume of 10 µL. PCR was conducted starting with a heat denaturation step at 94 ◦C for 5 min, followed
by 35 cycles of heat denaturation at 90 ◦C for 30 s, annealing for 60 s, and extension at 72 ◦C for 1.5 min,
and a final extension at 72 ◦C for 5 min. The PCR annealing temperatures for MTXA and MTXB were
61 ◦C and 62.8 ◦C, respectively. Fragments were visualized with Gel Red in a 1% agarose gel after
electrophoresis. Additionally, the PCR product generated with the primers for acidic subunit from
individual CSS11 was further purified and sequenced at the Massive DNA Sequence Unit, Instituto de
Biotecnología, UNAM to corroborate that the fragment amplified corresponded to MTXA.
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5.4. Protein Concentration Determination
The protein concentration in the venoms was determined in triplicate using the Pierce R©
Bicinchoninic Acid (BCA) Protein Assay (Thermo Scientific, Rockford, IL, USA) using bovine serum
albumin (BSA) as a standard, according to the manufacturer’s instruction. All analyses that used
venom used this to control for the protein concentration.
5.5. Mojave Toxin Detection by Sandwich ELISA
ELISA plates (Nunc MaxiSorp) were sensitized for 1 h at 37 ◦C with 100 µL per well of the
monoclonal antibody 4F6 against the basic subunit of Crotoxin to a final concentration of 5 µg/mL
in sensitization solution (100 mM NaHCO3, pH 9.5). Then, plates were washed twice with 200 µL of
wash solution (50 mM Tris/HCl, pH 8 + 150 mM NaCl + 0.05% Tween 20); this step was repeated after
every ELISA step. Plates were blocked with blocking buffer (50 mM Tris/HCl, pH 8 + 0.5% gelatin +
0.2% Tween 20) for 2 h at 37 ◦C. A standard curve with purified basic subunit of Crotoxin was prepared
to 2 µg/mL by making serial dilutions (1:3). In addition, 150 µL of serial dilutions (1:3) of each venom
(20 µg/mL) was added per well and incubated for 1 h at 37 ◦C. One hundred microliters of rabbit
polyclonal antibodies against Crotoxin (1 µg/mL) were added per well and incubated 1 h at 37 ◦C.
Rabbit anti-IgG antibodies conjugated to horseradish peroxidase (HRP) diluted 1:4000 were added
and incubated for 1 h at 37 ◦C. Finally, plates were revealed by adding 100 µL of revealing buffer
(containing 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)). Absorbance was read at 405 nm
using a spectrophotometer (Magallan R©).
5.6. Median Lethal Dose (LD50)
LD50 analysis was carried out as described in Borja et al. [35]. Freeze-dried venoms were
redissolved in phosphate buffer solution (PBS), pH 7.2. The lethal dose was determined by injecting
different quantities of venom diluted in a total volume of 0.5 mL into the caudal vein of male and
female ICR- CD1 mice (18 to 20 g) in groups of three. The percentage of dead mice 24 h after inoculation
was plotted against the logarithm of the quantity of venom injected and analyzed with nonparametric
methods using the program GraphPad Prism V4.0b.
5.7. Hemorrhagic Activity
Hemorrhagic activity was assessed using a modification of the technique described by
Dagda et al. [41]. Briefly, 15 µg of each venom dissolved in a total volume of 50 µL PBS was injected
subcutaneously in the shaved backs of five mice including both males and females from the ICR-CD1
strain (from 28–30 g). After 3 h, the mice were sacrificed by CO2 inhalation and the dorsal skin was
removed and extended over a glass plate. Afterward, the halo of hemorrhage produced by each venom
was measured to obtain the average hemorrhagic halo generated. Hemorrhagic activity is reported on
a relative scale from 0 to 4, where 4 indicates high hemorrhagic activity (hemorrhagic are greater than
20 mm in diameter) and 0 indicates no hemorrhagic activity [41].
5.8. Hide Powder Azure (HPA) Hydrolysis
Hydrolysis of hide powder azure was determined by adding 100 µg of venom to 1 mL of a solution
containing 5 mg of HPA in 0.1 M Tris-HCl, pH 8.0. After 2 h of incubation, the reaction was stopped
by centrifugation at 14,000 rpm for 5 min. Optical absorbance of the supernatant was determined at
595 nm. Each sample was tested in triplicate. A standard curve of HPA hydrolysis was done adding
50 µL of trypsin (2 mg/mL) to three concentrations of HPA (2, 4 and 6 mg/mL). Venom enzymatic
activity was calculated using the standard curve. A unit of enzymatic activity (U) was defined as the
amount of venom necessary to digest 1 mg of HPA in a 2 h period at room temperature and reported
as specific activity (U/mg) [49].
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5.9. Reverse Phase HPLC for MTX and SVMPs Detection
Venom proteins were separated by reverse phase HPLC on an analytic C18 reverse-phase column
(Vydac R©, Deerfield, IL, USA, 218 TP 4.6 mm × 250 mm) using an Agilent 1100 chromatograph.
In brief, each venom (1 mg) was dissolved in 1.7 mL of water containing 0.1% trifluoroacetic acid
(TFA). Elution was performed as described by Neri-Castro et al. [27] at 1 mL/min by applying a
gradient toward solution B (acetonitrile, containing 0.1% TFA), as follows: 0% B for 5 min, 0 to 15%
B over 10 min, 15 to 45% B over 60 min, 45 to 70% B over 10 min, and 70% B for 9 min. Proteins
were detected at 215 nm. For one sample (CSS33), we collected and dried the fractions that eluted
at approximately 42 and 52 min and for another sample (CSS22) we collected and dried the effluent
collected after 78 min. The fraction that eluted at 42 min likely corresponds to the acidic subunit of
Mojave toxin. To verify this, the protein sequence was obtained by tandem mass spectrometry of
peptides after digestion of the DTT-reduced and iodoacetamide-alkylated protein with trypsin and
analyzed by MALDI-TOF-TOF mass spectrometry on a Proteomic Analyzer 4800-Plus instrument
(Applied Biosystems) at the Instituto Clodomiro Picado in Costa Rica. The fraction eluted at 52 min
was analyzed by Mass Spectrometry (LCQ Fleet Ion Trap Mass Spectrometer) and N-terminal sequence
analysis (PPSQ-31A Protein Sequencer) to verify MTXB presence and fractions eluted after 78 min were
used in Western blot analysis using antibodies against SVMPs to verify SVMP presence. The relative
abundance (% of the total venom proteins) of SVMPs in seventeen venoms (including controls) was
calculated based on the relation of the sum of the areas of the reverse-phase chromatographic peaks
eluted after 78 min, which is the time SVMPs begin to elute [27]. Relationship between the SVMPs
percentage in venoms and proteolytic activity (HPA hydrolysis) was analyzed using linear regression.
Significant was determined at the level of p < 0.05.
5.10. SVMP Detection by Western Blot
Reverse-phase HPLC fractions eluted after 78 min and whole crude Type A, Type B and CSS22
(as Type A + B Mexican venom control) venoms (15 µg) were separated using SDS-PAGE under
reducing conditions (in the presence of β-mercaptoethanol). After electrophoresis, proteins were
transferred to a nitrocellulose membrane using a model HEP-1 semi-dry immunotransference chamber
(Thermo Scientific). After transference at 400 mA for 1 h, the membrane was blocked with 5% non-fat
dry milk diluted in TBST buffer (0.01 M Tris-HCl + 0.15M NaCl + 0.05% of Tween-20, pH 7.5) for 2 h.
The membrane was then rinsed three times with TBST and incubated by shaking gently for 1 h at
∼28 ◦C (room temperature) with rabbit antibodies against P-III SVMPs from C. simus in a concentration
of 1 µg/mL diluted in 10 mL TBST. After three washes with TBST, the membrane was incubated at
room temperature for 1 h with goat antibodies anti-rabbit IgG conjugated to horseradish peroxidase
(Thermo Scientific). The membrane was again rinsed with TBST and then developed by adding 1-Step
Ultra TMB substrate (Thermo Scientific, Rockford, IL, USA). Purified P-III SVMPs, SVSPs, and Crotoxin
were used as controls.
5.11. SDS-PAGE
The discontinuous system was used on a Miniprotean III system (BioRad). Venom samples
(15 µg) were dissolved in sample buffer (50 mM Tris- HCl, pH 6.8, 25% SDS, 10% glycerol, and 0.002%
bromo- phenol blue), in the presence of 5% β-mercaptoethanol. Samples were boiled for 5 min and run
on a 15% acrylamide gel. Gels were stained with 0.2% Coomassie brilliant blue R-250, 10% acetic acid,
and 25% methanol for 1 h and rinsed in 10% acetic acid and 10% methanol [35]. Standard molecular
mass markers (Bio-Rad) were used as references. To compare electrophoretic profile between pooled
and individual Type A and Type B venoms from the United States, an additional set of pooled
Type A and Type B venoms from The National Natural Toxins Research Center were separated by
SDS-PAGE too.
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Appendix A. RP-HPLC Chromatograms
Figure A1. Reverse-phase HPLC chromatograms not shown in Figure 2 of the three C. s. scutulatus
venom types found in Mexico: (A–E) Type B venoms from Mexico; (F–H) Type A venoms from Mexico;
and (I) Type A + B venom from Mexico. Retention time is along the x axis for each panel and labeled
every twenty minutes. Proteins were detected at 215 nm and absorbance is indicated on the left axis.
The acetonitrile gradient is shown in the HPLC graph and the percentage value corresponds to the
right axis for each panel. Acidic (MTXA) and basic (MTXB) subunits of Mojave toxin and snake venom
metalloproteinases (SVMPs) are illustrated in blue, green and red, respectively.
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